PortfoliosLab logoPortfoliosLab logo
BBP vs. SPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBP vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBP achieves a 5.80% return, which is significantly lower than SPY's 10.91% return. Over the past 10 years, BBP has underperformed SPY with an annualized return of 11.61%, while SPY has yielded a comparatively higher 15.49% annualized return.


BBP

1D
1.18%
1M
-3.14%
YTD
5.80%
6M
7.91%
1Y
45.02%
3Y*
16.70%
5Y*
10.37%
10Y*
11.61%

SPY

1D
-0.70%
1M
5.05%
YTD
10.91%
6M
10.91%
1Y
27.98%
3Y*
22.35%
5Y*
13.83%
10Y*
15.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBP vs. SPY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBP
Virtus LifeSci Biotech Products ETF
5.80%33.15%3.32%17.88%0.85%-8.17%22.24%24.73%-13.95%24.07%
SPY
State Street SPDR S&P 500 ETF
10.91%17.72%24.89%26.18%-18.18%28.73%18.33%31.22%-4.57%21.71%

Correlation

The correlation between BBP and SPY is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.49

Correlation (3Y)
Calculated over the trailing 3-year period

0.52

Correlation (5Y)
Calculated over the trailing 5-year period

0.54

Correlation (10Y)
Calculated over the trailing 10-year period

0.55

Correlation (All Time)
Calculated using the full available price history since Dec 18, 2014

0.55

The correlation between BBP and SPY has been stable across timeframes, ranging from 0.49 to 0.55 - a consistent structural relationship.

BBP vs. SPY - Sectors Allocation Comparison


Sectors
BBP
SPY

Healthcare

100.0%
8.4%

Basic Materials

-

1.8%

Communication Services

-

11.3%

Consumer Cyclical

-

10.3%

Consumer Defensive

-

4.8%

Energy

-

3.6%

Financial Services

-

11.8%

Industrials

-

7.8%

Real Estate

-

1.9%

Technology

-

35.9%

Utilities

-

2.4%

Healthcare

BBP
100.0%
SPY
8.4%

Basic Materials

BBP

-

SPY
1.8%

Communication Services

BBP

-

SPY
11.3%

Consumer Cyclical

BBP

-

SPY
10.3%

Consumer Defensive

BBP

-

SPY
4.8%

Energy

BBP

-

SPY
3.6%

Financial Services

BBP

-

SPY
11.8%

Industrials

BBP

-

SPY
7.8%

Real Estate

BBP

-

SPY
1.9%

Technology

BBP

-

SPY
35.9%

Utilities

BBP

-

SPY
2.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBP vs. SPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBP
BBP Risk / Return Rank: 6565
Overall Rank
BBP Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
BBP Sortino Ratio Rank: 5656
Sortino Ratio Rank
BBP Omega Ratio Rank: 5050
Omega Ratio Rank
BBP Calmar Ratio Rank: 8686
Calmar Ratio Rank
BBP Martin Ratio Rank: 7979
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 7070
Overall Rank
SPY Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 6969
Sortino Ratio Rank
SPY Omega Ratio Rank: 7070
Omega Ratio Rank
SPY Calmar Ratio Rank: 6262
Calmar Ratio Rank
SPY Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBP vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BBPSPYDifference
Sharpe ratioReturn per unit of total volatility

-0.47

Sortino ratioReturn per unit of downside risk

-0.51

Omega ratioGain probability vs. loss probability

1.32

1.43

-0.11

Calmar ratioReturn relative to maximum drawdown

4.87

3.16

+1.71

Martin ratioReturn relative to average drawdown

15.32

14.72

+0.60

BBP vs. SPY - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 1.91, which is comparable to the SPY Sharpe Ratio of 2.38. The chart below compares the historical Sharpe Ratios of BBP and SPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BBPSPYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.91

2.38

-0.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

0.82

-0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.42

0.87

-0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

0.59

-0.19

Drawdowns

BBP vs. SPY - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BBP and SPY.


Loading charts...

Drawdown Indicators


BBPSPYDifference

Max Drawdown

Largest peak-to-trough decline

-44.32%

-55.19%

+10.87%

Max Drawdown (1Y)

Largest decline over 1 year

-9.28%

-8.88%

-0.40%

Max Drawdown (3Y)

Largest decline over 3 years

-26.09%

-18.76%

-7.33%

Max Drawdown (5Y)

Largest decline over 5 years

-38.28%

-24.50%

-13.78%

Max Drawdown (10Y)

Largest decline over 10 years

-44.32%

-33.72%

-10.60%

Current Drawdown

Current decline from peak

-6.47%

-0.70%

-5.77%

Average Drawdown

Average peak-to-trough decline

-12.02%

-9.05%

-2.97%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.95%

1.91%

+1.04%

Volatility

BBP vs. SPY - Volatility Comparison

Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 7.61% compared to State Street SPDR S&P 500 ETF (SPY) at 2.84%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBPSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.61%

2.84%

+4.77%

Volatility (6M)

Calculated over the trailing 6-month period

18.43%

8.90%

+9.53%

Volatility (1Y)

Calculated over the trailing 1-year period

23.76%

11.83%

+11.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.35%

17.05%

+9.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.40%

17.94%

+9.46%

BBP vs. SPY - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than SPY's 0.09% expense ratio.


Dividends

BBP vs. SPY - Dividend Comparison

BBP has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.98%.


PositionTTM20252024202320222021202020192018201720162015
BBP
Virtus LifeSci Biotech Products ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%
SPY
State Street SPDR S&P 500 ETF
0.98%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Frequently Asked Questions


BBP and SPY have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBP has higher volatility (7.61%) compared to SPY (2.84%). In terms of maximum drawdown, BBP dropped -44.32% vs SPY's -55.19%.

On 10-year performance, SPY leads with 15.49% vs 11.61% for BBP. On fees, SPY is cheaper at 0.09% per year. On volatility, SPY has been the lower-risk option at 2.84%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SPY has performed better with a 15.49% return vs 11.61%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SPY is cheaper with a 0.09% expense ratio, compared with 0.79% for BBP.

SPY has the higher dividend yield at 0.98%, compared with 0.00% for BBP.

BBP is categorized as Health & Biotech Equities, while SPY is S&P 500. BBP tracks LifeSci Biotechnology Products Index, while SPY tracks S&P 500 Index. They also come from different issuers: Virtus Investment Partners and State Street. Their fees differ too: 0.79% for BBP and 0.09% for SPY.

SPY currently has the higher Sharpe Ratio (2.38 vs 1.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBP and SPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer